Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trabedersen

EU orphan designation number: EU/3/09/660   
Active ingredient: Trabedersen
Indication: Treatment of pancreatic cancer
Sponsor: Isarna Therapeutics GmbH
Leopoldstr. 254-256, 80807 München, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2009 Centralised Orphan - Designation EMEA/OD/030/09 (2009)6028 of 24/07/2009
04/02/2014 Centralised Orphan - Change of address